Arovella Therapeutics Limited (E4NA) Q2 2021 Earnings Report
DE:E4NA Q2 2021 EPS Results
- Actual EPS
- -EUR 0.38
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.03
DE:E4NA Q2 2021 Revenue Results
- Actual Revenue
- EUR 148.00K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -34.42%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 02/26/2021
- Time
- TBA
- Conference Call
- Friday, February 26, 2021
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:E4NA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 02, 2026 | 2026 (Q4) | ―-0.00 | 0 | 33.33% (+0.00) | |
| Feb 19, 2026 | 2026 (Q2) | ―-0.00 | 0 | -100.00% (-0.00) | |
| Aug 27, 2025 | 2025 (Q4) | -0.00-0.00 | 0 | -20.00% (-0.00) | |
| Feb 26, 2025 | 2025 (Q2) | -0.00-0.00 | 0 | 75.00% (+0.00) | |
| Aug 21, 2024 | 2024 (Q4) | ―-0.00 | 0 | 37.50% (+0.00) | |
| Feb 28, 2024 | 2024 (Q2) | ―-0.00 | 0 | 33.33% (+0.00) | |
| Aug 31, 2023 | 2023 (Q4) | ―-0.00 | 0 | 0.00% (+0.00) | |
| Feb 22, 2023 | 2023 (Q2) | ―-0.00 | 0 | 25.00% (+0.00) | |
| Aug 31, 2022 | 2022 (Q4) | ―-0.00 | 0 | -14.29% (-0.00) | |
| Feb 27, 2022 | 2022 (Q2) | ―-0.00 | -0.38 | 98.73% (+0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed